HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes
批准号:
8423064
负责人:
MAHENDRA KUMAR
金额:
$57.27万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2016-01-31
关键词:
Acquired Immunodeficiency SyndromeAddressAdrenal GlandsAfrican AmericanAntibodiesCRH geneCaucasiansCaucasoid RaceCocaineCocaine AbuseComorbidityContractsCorticotropinCountryCytokine GeneDexamethasoneDrug abuseEndocrineEndocrine systemEuphoriaFloridaGene ExpressionGlucoseHIVHIV-1HispanicsHydrocortisoneHyperglycemiaHyperthyroidismIllicit DrugsIncidenceIndividualInfectionInflammatoryInsulinInsulin ResistanceInterventionInvestigationIodide PeroxidaseLeadMedicalMethamphetamineOpioidOutcomeOxidative StressParticipantPharmaceutical PreparationsPopulationReportingRisk FactorsRodentSyndromeTestingThyroid GlandTimeUnited Statesadverse outcomedrug abuserinsulin secretionmenmen who have sex with menmethamphetamine abusepublic health relevanceresponsetherapy design
中文摘要
描述(由申请人提供):HIV-1感染与内分泌系统的不良结局相关。非法药物滥用是感染HIV-1的一个主要危险因素,也与异常内分泌结果有关。包括我们在内的几项研究报告了吸毒HIV-1+个体的内分泌异常加剧。但这些调查是在可卡因和/或阿片类药物成瘾者中进行的,美国的药物滥用文化正在发生变化。甲基苯丙胺(冰毒)正在成为全国各地的首选药物,在南佛罗里达,特别是在男男性行为者中的滥用情况急剧上升。然而,关于甲基苯丙胺对HIV-1感染者内分泌影响的调查很少。据推测,肾上腺活动将增加,将有一个高活性的甲状腺以及胰岛素抵抗的发病率增加,在HIV-1+甲基滥用MSM。为了检验这些假设,这项为期5年的申请提出调查三组共450名男性的肾上腺、甲状腺和胰岛素活性:HIV-1+冰毒滥用者(n=150)、HIV-1-冰毒滥用者(n = 150)、HIV-1 -非冰毒滥用者(n =150),分布在非洲裔美国人、高加索人和西班牙裔美国人中。由于计划将重点放在男男性接触者身上,因此只有男性将被纳入研究。目标如下:目标1:目的:研究滥用冰毒的HIV-1+ MSM、滥用冰毒的HIV-1- MSM和HIV-1-无冰毒对照参与者的肾上腺活性(ACTH和皮质醇水平)以及对地塞米松-CRH联合激发的反应。目标二:目的:探讨吸毒HIV-1阳性MSM、吸毒HIV-1阳性MSM和HIV-1阴性对照人群的甲状腺功能(TSH、T4、T3)及甲状腺抗体水平。目的3:探讨吸毒HIV-1阳性MSM、吸毒HIV-1阳性MSM和HIV-1阴性对照人群的胰岛素活性。 这些内分泌紊乱可能导致大量严重的医疗后果和结果的巨大负担,并进一步允许开发合适的干预措施。
英文摘要
DESCRIPTION (provided by applicant): HIV-1 Infection is associated with adverse outcomes in endocrine systems. Illicit drug abuse is a major risk factor for contracting HIV-1 infection and is also associated with abnormal endocrine outcomes. Several studies including ours have reported exacerbated endocrine abnormalities among drug abusing HIV-1+ individuals. But these investigations have been carried out among cocaine and/or opioids addicts, and the culture of drug abuse in the United States is changing. Methamphetamine (meth) is becoming a drug of choice all over the country and its abuse in South Florida particularly among MSM has skyrocketed. There is, however, a scarcity of investigations on the impact of methamphetamine on endocrines in HIV-1 infection. It is hypothesized that adrenal activity will be increased, there will be a hyper activity of thyroid as well as an increased incidence of insulin resistance, among HIV-1+ meth abusing MSM. In order to test these hypotheses, this 5 year application proposes to investigate cross sectionally adrenal, thyroid, and insulin activity in a total of 450 men in three groups: HIV-1+ meth abusers (n=150), HIV-1- meth abusers (n=150), HIV-1 - non-meth abusers (n=150) distributed among African Americans, Caucasians, and Hispanics. Because of the planned focus on MSM, only men will be included in the study. The following are aims: Aim 1: To investigate adrenal activity (ACTH and cortisol levels) as well as response to the combined dexamethasone-CRH challenge among meth abusing-HIV-1+ MSM, meth abusing HIV-1- MSM and HIV-1- meth-free control participants. Aim 2: To investigate thyroid activity (TSH, T4 and T3) as well as thyroid antibodies among meth abusing-HIV-1+ MSM, meth abusing HIV-1- MSM and HIV-1- meth-free control participants. Aim 3: To explore insulin activity among meth abusing-HIV-1+ MSM; meth abusing HIV-1- MSM and HIV-1- meth-free control participants. These endocrine disturbances may lead to enormous burden of a number of serious medical consequences and outcomes in meth abusing MSM and further allow developing suitable interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes
-
批准号:8603232
-
项目类别:
-
资助金额:$59.49万
-
财政年份:2011
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes
-
批准号:8241013
-
项目类别:
-
资助金额:$59.83万
-
财政年份:2011
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes
-
批准号:8803376
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2011
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes
-
批准号:8155014
-
项目类别:
-
资助金额:$60.28万
-
财政年份:2011
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 C Clade Progression and NeuroAIDS
-
批准号:7281781
-
项目类别:
-
资助金额:$48.05万
-
财政年份:2006
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 C Clade Progression and NeuroAIDS
-
批准号:7168348
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2006
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 C Clade Progression and NeuroAIDS
-
批准号:7631194
-
项目类别:
-
资助金额:$47.72万
-
财政年份:2006
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 C Clade Progression and NeuroAIDS
-
批准号:7436220
-
项目类别:
-
资助金额:$47.45万
-
财政年份:2006
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 C Clade Progression and NeuroAIDS
-
批准号:7874442
-
项目类别:
-
资助金额:$48.01万
-
财政年份:2006
-
负责人:MAHENDRA KUMAR
-
依托单位:
CORE--ENDOCRINOLOGY
-
批准号:6592847
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2002
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1/HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION
-
批准号:6348502
-
项目类别:
-
资助金额:$44.62万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
CORE--ENDOCRINOLOGY
-
批准号:6468014
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
CORE--ENDOCRINOLOGY
-
批准号:6580456
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 & HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION
-
批准号:6790545
-
项目类别:
-
资助金额:$47.67万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV1 + IDU's--ENDOCRINE CONSEQUENCES & MEDICAL OUTCOMES
-
批准号:6348453
-
项目类别:
-
资助金额:$57.97万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 & HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION
-
批准号:6650844
-
项目类别:
-
资助金额:$46.28万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 & HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION
-
批准号:6931919
-
项目类别:
-
资助金额:$48.98万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV-1 & HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION
-
批准号:6529687
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV1 + IDU's--ENDOCRINE CONSEQUENCES & MEDICAL OUTCOMES
-
批准号:6634321
-
项目类别:
-
资助金额:$71.94万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
HIV1 + IDU's--ENDOCRINE CONSEQUENCES & MEDICAL OUTCOMES
-
批准号:6891856
-
项目类别:
-
资助金额:$64.51万
-
财政年份:2001
-
负责人:MAHENDRA KUMAR
-
依托单位:
海外基金